Quantcast
Last updated on April 18, 2014 at 21:20 EDT

Latest Teva Canada Limited Stories

2012-11-08 12:28:02

Decision will result in increased access and significant cost savings for Canadian consumers TORONTO, Nov. 8, 2012 /CNW/ - Today's decision by the Supreme Court of Canada paves the way for pharmaceutical manufacturer, Teva Canada Limited, to begin marketing Sildenafil Citrate tablets, the generic version of Viagra®. The ruling comes more than five years after proceedings were initiated by Teva Canada under the Patented Medicines (Notice of Compliance) Regulations challenging the...